Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...


CLIN-1601-101 - Chondrial Therapeutics Phase I study of CTI-1601, a frataxin replacement therapy

Participants are needed for a a Phase I research study to test an investigational medication in individuals with Friedreich's ataxia.

You May Be Eligible if You:

  • Are 18 years of age or older
  • Have genetically confirmed Friedreich's Ataxia
  • Are able to traverse 25 feet with or without an assistive device
  • Are able to perform basic daily care

Please see this recruitment flyer for other Key Inclusion Criteria and contact information.

About the Author

Jen Farmer

Jen Farmer

Executive Director


Science D.jpg
Site Map     Privacy Policy     Service Terms     Log-in     Contact     Charity Navigator